D, Lott JA. Clinical evaluation of an immunoinhibition procedure for creatine kinase-MB. Clin Chem. 1980 Jan;26(1):150-2. \[[PubMed: 7356551](https://pubmed.ncbi.nlm.nih.gov/7356551)\] 33. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44(3):311-6. \[[PubMed: 16519604](https://pubmed.ncbi.nlm.nih.gov/16519604)\] 34. Hedayati M, Razavi SA, Boroomand S, Kheradmand Kia S. The impact of pre-analytical variations on biochemical analytes stability: A systematic review. J Clin Lab Anal. 2020 Dec;34(12):e23551. \[[PMC free article: PMC7755813](/pmc/articles/PMC7755813/)\] \[[PubMed: 32869910](https://pubmed.ncbi.nlm.nih.gov/32869910)\] 35. Timonen A, Lloyd-Puryear M, Hougaard DM, Meriö L, Mäkinen P, Laitala V, Pölönen T, Skogstrand K, Kennedy A, Airenne S, Polari H, Korpimäki T. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP® Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int J Neonatal Screen. 2019 Sep;5(3):27. \[[PMC free article: PMC7510235](/pmc/articles/PMC7510235/)\] \[[PubMed: 33072986](https://pubmed.ncbi.nlm.nih.gov/33072986)\] 36. Zaninotto M, Mion MM, Novello E, Delprete E, Moretti M, Plebani M. Creatine-kinase MB mass: age and sex-associated reference limits in two different platforms that use the same method. Clin Chim Acta. 2009 Mar;401(1-2):162-4. \[[PubMed: 19101529](https://pubmed.ncbi.nlm.nih.gov/19101529)\] 37. Stäubli M, Roessler B, Köchli HP, Peheim E, Straub PW. Creatine kinase and creatine kinase MB in endurance runners and in patients with myocardial infarction. Eur J Appl Physiol Occup Physiol. 1985;54(1):40-5. \[[PubMed: 4018053](https://pubmed.ncbi.nlm.nih.gov/4018053)\] 38. el Allaf M, Chapelle JP, el Allaf D, Adam A, Faymonville ME, Laurent P, Heusghem C. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clin Chem. 1986 Feb;32(2):291-5. \[[PubMed: 3510780](https://pubmed.ncbi.nlm.nih.gov/3510780)\] 39. Wolfson D, Lindberg E, Su L, Farber SJ, Dubin SB. Three rapid immunoassays for the determination of creatine kinase MB: an analytical, clinical, and interpretive evaluation. Am Heart J. 1991 Oct;122(4 Pt 1):958-64. \[[PubMed: 1927882](https://pubmed.ncbi.nlm.nih.gov/1927882)\] 40. Mathey D, Bleifeld W, Buss H, Hanrath P. Creatine kinase release in acute myocardial infarction: correlation with clinical, electrocardiographic, and pathological findings. Br Heart J. 1975 Nov;37(11):1161-8. \[[PMC free article: PMC482934](/pmc/articles/PMC482934/)\] \[[PubMed: 1191432](https://pubmed.ncbi.nlm.nih.gov/1191432)\] 41. Apple FS. Diagnostic use of CK-MM and CK-MB isoforms for detecting myocardial infarction. Clin Lab Med. 1989 Dec;9(4):643-54. \[[PubMed: 2686906](https://pubmed.ncbi.nlm.nih.gov/2686906)\] 42. Tricoci P, Leonardi S. Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither? MLO Med Lab Obs. 2015 Jan;47(1):14, 16. \[[PubMed: 26281113](https://pubmed.ncbi.nlm.nih.gov/26281113)\] 43. Sadoh WE, Eregie CO, Nwaneri DU, Sadoh AE. The diagnostic value of both troponin T and creatinine kinase isoenzyme (CK-MB) in detecting combined renal and myocardial injuries in asphyxiated infants. PLoS One. 2014;9(3):e91338.